Is BCRX a good stock to buy? We came across a bullish thesis on BioCryst Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on BCRX. BioCryst Pharmaceuticals, Inc.’s share was trading at $8.33 as of June 9th. BCRX’s trailing and forward P/E were 7.46 and 72.99 respectively according to Yahoo Finance.
Copyright: dolgachov / 123RF Stock Photo
BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing...
